Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures

DMM Disease Models and Mechanisms

Volumn 5, Issue 6, 2012, Pages 773-784

  Baxendale, Sarah ^a   Holdsworth, Celia J ^a   Meza Santoscoy, Paola L ^a   Harrison, Michael R M ^a   Fox, James ^a   Parkin, Caroline A ^a   Ingham, Philip W ^a   Cunliffe, Vincent T ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CELL NUCLEUS RECEPTOR; DIOXYBENZONE; ETHINYLESTRADIOL; HEXYLRESORCINOL; NEROLIDOL; NIMODIPINE; NITRENDIPINE; PENTETRAZOLE; PIMOZIDE; STEROID; SULCONAZOLE; SULOCTIDIL;

ANIMAL MODEL; ANTICONVULSANT ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; DRUG IDENTIFICATION; EMBRYO; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HEART FUNCTION; HYBRIDIZATION; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; LARVA; LOCOMOTION; MOLECULAR LIBRARY; MUSCLE CELL; NERVE CELL; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; ZEBRA FISH;

ANIMALS; ANTICONVULSANTS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EMBRYO, NONMAMMALIAN; EPILEPSY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IN SITU HYBRIDIZATION; LARVA; MOTOR ACTIVITY; MUSCLES; ORGAN SPECIFICITY; PENTYLENETETRAZOLE; PICROTOXIN; SMALL MOLECULE LIBRARIES; ZEBRAFISH;

ANIMALIA; DANIO RERIO;

EID: 84870028642     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.010090     Document Type: Article

References (55)

1. Anandahan, A., Tamilselvan, K., Radhiga, T., Rao, S., Essa, M. M. and Manivasagam, T. (2012). Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease. Brain Res. 1433, 104-113.
2. Baraban, S. C. (2007). Emerging epilepsy models: insights from mice, flies, worms and fish. Curr. Opin. Neurol. 20, 164-168.
3. Baraban, S. C., Hollopeter, G., Erickson, J. C., Schwartzkroin, P. A. and Palmiter, R. D. (1997). Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 17, 8927-8936. (Pubitemid 27498421)
4. Baraban, S. C., Taylor, M. R., Castro, P. A. and Baier, H. (2005). Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 131, 759-768. (Pubitemid 40261229)
5. Berghmans, S., Hunt, J., Roach, A. and Goldsmith, P. (2007). Zebrafish offer the potential for a primary screen to identify a wide range of potential anticonvulsants. Epilepsy Res. 75, 18-28. (Pubitemid 46856115)
6. Bozzi, Y., Dunleavy, M. and Henshall, D. C. (2011). Cell signaling underlying epileptic behavior. Front. Behav. Neurosci. 5, 45.
7. Buchholtz, V., Leuwer, M., Ahrens, J., Foadi, N., Krampfl, K. and Haeseler, G. (2009). Topical antiseptics for the treatment of sore throat block voltage-gated sodium channels in a local anaesthetic-like manner. Naunyn Schmiedebergs Arch. Pharmacol. 380, 161-168.
8. Cachat, J., Stewart, A., Grossman, L., Gaikwad, S., Kadri, F., Chung, K. M., Wu, N., Wong, K., Roy, S., Suciu, C. et al. (2010). Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nature Protoc. 5, 1786-1799.
9. Cachat, J., Stewart, A., Utterback, E., Hart, P., Gaikwad, S., Wong, K., Kyzar, E., Wu, N. and Kalueff, A. V. (2011). Three-dimensional neurophenotyping of adult zebrafish behavior. PLoS ONE 6, e17597.
10. Chang, P., Orabi, B., Deranieh, R. M., Dham, M., Hoeller, O., Shimsoni, J. A., Yagen, B., Bialer, M., Greenberg, M. L., Walker, M. C. et al. (2012). The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium. Dis. Model. Mech. 5, 115-124.
11. Colman, J. R., Baldwin, D., Johnson, L. L. and Scholz, N. L. (2009). Effects of the synthetic estrogen, 17a-ethinylestradiol, on aggression and courtship behavior in male zebrafish (Danio rerio). Aquatic Toxicol. 91, 346-354.
12. Coyne, L., Su, J., Patten, D. and Halliwell, R. F. (2007). Characterization of the interaction between fenamates and hippocampal neuron GABAA receptors. Neurochem. Int. 51, 440-446. (Pubitemid 47503467)
13. Cramer, J. A., Mintzer, S., Wheless, J. and Mattson, R. H. (2010). Adverse effcts of antiepileptic drugs: a brief overview of important issues. Expert Rev. Neurother. 10, 885-891.
14. Darland, T. and Dowling, J. E. (2001). Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc. Natl. Acad. Sci. USA 98, 11691-11696. (Pubitemid 32928790)
15. Dhir, A., Naidu, P. S. and Kulkarni, S. K. (2005). Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazole-induced kindling in mice. Clin. Exp. Pharmacol. Physiol. 32, 574-584.
16. Feldman, D. (1986). Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. Endocr. Rev. 7, 409-420.
17. Greenberg, M. E., Xu, B., Lu, B. and Hempstead, B. L. (2009). New insights in the biology of BDNF synthesis and release: implications in CNS function. J. Neurosci. 29, 12764-12767.
18. Greer, P. L. and Greenberg, M. E. (2008). From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function. Neuron 59, 846-860.
19. Heilig, M. (2004). The NPY system in stress, anxiety and depression. Neuropeptides 38, 213-224.
20. Hortopan, G. A., Dinday, M. T. and Baraban, S. C. (2010a). Spontaneous seizures and altered gene expression in GABA signaling pathways in a mind bomb mutant zebrafish. J. Neurosci. 30, 13718-13728.
21. Hortopan, G. A., Dinday, M. T. and Baraban, S. C. (2010b). Zebrafish as a model for studying genetic aspects of epilepsy. Dis. Model. Mech. 3, 144-148.
22. A receptors through two discrete transmembrane sites. Nature 444, 486-489.
23. Huang, R. Q., Bell-Horner, C. L., Dibas, M. I., Covey, D. F., Drewe, J. A. and Dillon, G. H. (2001). Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action. J. Pharmacol. Exp. Ther. 298, 986-995. (Pubitemid 32761913)
24. Kaminski, R. M., Marini, H., Kim, W. J. and Rogawski, M. A. (2005). Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia 46, 819-827. (Pubitemid 40847350)
25. Kokel, D., Bryan, J., Laggner, C., White, R., Cheung, C. Y. J., Mateus, R., Healey, D., Kim, S., Werdich, A. A., Haggarty, S. J. et al. (2010). Rapid behavior-based identification of neuroactive small molecules in zebrafish. Nat. Chem. Biol. 6, 231-237.
26. Lin, Y., Bloodgood, B. L., Hauser, J. L., Lapan, A. D., Koon, A. C., Kim, T.-K., Hu, L. S., Malik, A. N. and Greenberg, M. E. (2008). Activity-dependent regulation of inhibitory synapse development by Npas4. Nature 455, 1198-1204.
27. Lipsky, R. H. and Marini, A. M. (2007). Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann. N. Y. Acad. Sci. 1122, 130-143. (Pubitemid 350249544)
28. Loebrich, S. and Nedivi, E. (2009). The function of activity-regulated genes in the nervous system. Physiol. Rev. 89, 1079-1103.
29. Löscher, W. (2011). Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 20, 359-368.
30. Luszczki, J. J., Andres-Match, M., Glensk, M. and Salicka-Wozniak, K. (2010). Anticonvulsant effects of four linear furanocoumarins, bergapten, imperatorin, oxypeucedanin, and xanthotoxin, in the mouse maximal electroshock-induced seizure model: a comparative study. Pharmacol. Rep. 62, 1231-1236.
31. Mahé, C., Loetscher, E., Feuerbach, D., Müller, W., Seiler, M. P. and Schoeffter, P. (2004). Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. Eur. J. Pharmacol. 495, 97-102. (Pubitemid 38891865)
32. Mishra, R. and Ganguly, S. (2012). Imidazole as an anti-epileptic: an overview. Med. Chem. Res. doi: 10.1007/s00044-012-9972-6.
33. Nalivaeva, N. N., Belyaev, N. D. and Turner, A. J. (2009). Sodium valproate: an old drug with new roles. Trends Pharmacol. Sci. 30, 509-514.
34. Norton, W. H. and Bally-Cuif, L. (2010). Adult zebrafish as a model organism for behavioural genetics. BMC Neuroscience 11, 90.
35. Pack, A. M., Reddy, D. S., Duncan, S. and Herzog, A. (2011). Neuroendocrinological aspects of epilepsy: important issues and trends in future research. Epilepsy Behav. 22, 94-102.
36. Picazo, O., Becerril-Montes, A., Huidobro-Perez, D. and Garcia-Segura, L. M. (2010). Neuroprotective actions of the synthetic estrogen 17a-Ethynylestradiol in the hippocampus. Cell. Mol. Neurobiol. 30, 675-682.
37. Reddy, D. S. (2010). Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog. Brain Res. 186, 113-137.
38. Reddy, D. S., Castaneda, D. C., O'Malley, B. W. and Rogawski, M. A. (2004). Anticonvulsant activity of Progesterone and Neurosteroids in Progesterone Receptor knockout mice. J. Pharmacol. Exp. Ther. 310, 230-239. (Pubitemid 38812716)
39. Reid, C. A., Berkovic, S. F. and Petrou, S. (2009). Mechanisms of human inherited epilepsies. Prog. Neurobiol. 87, 41-57.
40. Remy, S. and Beck, H. (2006). Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 129, 18-35. (Pubitemid 43063756)
41. Sarang, S. S., Yoshida, T., Cadet, R., Valeras, A. S., Jensen, R. V. and Gullans, S. R. (2002). Discovery of molecular mechanisms of neuroprotection using cell-based assays and oligonucleotide arrays. Physiol. Genomics 11, 45-52. (Pubitemid 37128721)
42. Seeman, P. (2002). Atypical antipsychotics: mechanism of action. Can. J. Psychiatry 47, 27-38.
43. Stafstrom, C. E. (2010). Mechanisms of action of antiepileptic drugs: the search for synergy. Curr. Opin. Neurol. 23, 157-163.
44. Steenbergen, P. J., Richardson, M. K. and Champagne, D. L. (2011). The use of the zebrafish model in stress research. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 1432-1451.
45. Stewart, A. M., Desmond, D., Kyzar, E., Gaikwad, S., Roth, A., Riehl, R., Collins, C., Monnig, L., Green, J. and Kalueff, A. V. (2012). Perspectives of zebrafish models of epilepsy: what, how and where next? Brain Res. Bull. 87, 135-143.
46. Thisse, C. and Thisse, B. (2008). High resolution in situ hybridisation to whole-mount zebrafish embryos. Nature Protoc. 3, 59-69.
47. Thorsell, A. (2010). Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. Exp. Biol. Med. 235, 1163-1167.
48. Tian, L., Hires, S. A., Mao, T., Huber, D., Chiappe, M. E., Chalasani, S. H., Petreanu, L., Akerboom, J., McKinney, S. A., Schreiter, E. R. et al. (2009). Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators. Nat. Methods 6, 875-881.
49. Tochman, A. M., Kaminski, R., Turski, W. A. and Czuczwar, S. J. (2000). Protection by conventional and new antiepileptic drugs against lindane-induced seizures and lethal effects in mice. Neurotox. Res. 2, 63-70.
50. Tutka, P., Luszczki, J., Kleinrok, Z., Arent, K. and Wielosz, M. (2002). Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice. J. Neural Transmission 109, 455-466. (Pubitemid 34280404)
51. A and glycine-gated chlorine channels in primary cultures of cerebellar granule cells. Neuroscience 117, 397-403.
52. Von Hofsten, J., Elworthy, S., Gilchrist, M. J., Smith, J. C., Wardle, F. C., Ingham, P. W. (2008). Prdm1- and Sox6-mediated transcriptional repression specifies muscle fibre-type in the zebrafish embryo. EMBO Rep. 9, 683-689. (Pubitemid 351927690)
53. Wallenstein, M. C. (1991). Attenuation of epileptogenesis by nonsteroidal antiinflammatory drugs in the rat. Neuropharmacology 30, 657-663.
54. Winter, M. J., Redfern, W. S., Hayfield, A. J., Owen, S. F., Valentin, J. P. and Hutchinson, T. H. (2008). Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. J. Pharm. Toxicol. Methods 57, 176-187.
55. Zhang, J., Zhang, D., McQuade, J. S., Behbehani, M., Tsien, J. Z. and Xu, M. (2002). c-fos regulates neuronal excitability and survival. Nat. Genet. 30, 416-420.